首页> 外国专利> METHODS FOR USING A DNA EXPRESSION BUILDING; Use two or three DNA expression constructs; USING DNA EXPRESSION CONSTRUCTIONS FOR THE PRODUCTION OF A VACCINE FOR TREATMENT OF DISEASES OF LEISHMANIOSIS INFECTIONS; USING TWO OR THREE CONSTRUCTIONS FOR DNA EXPRESSION FOR PRODUCTION OF A VACCINE FOR TREATMENT OF DISEASES OF LEISHMANIOSIS INFECTIONS; DNA EXPRESSION CONSTRUCTIONS; AND VACCINE FOR TREATMENT OF DISEASES OF LEISHMANIOSIS INFECTIONS

METHODS FOR USING A DNA EXPRESSION BUILDING; Use two or three DNA expression constructs; USING DNA EXPRESSION CONSTRUCTIONS FOR THE PRODUCTION OF A VACCINE FOR TREATMENT OF DISEASES OF LEISHMANIOSIS INFECTIONS; USING TWO OR THREE CONSTRUCTIONS FOR DNA EXPRESSION FOR PRODUCTION OF A VACCINE FOR TREATMENT OF DISEASES OF LEISHMANIOSIS INFECTIONS; DNA EXPRESSION CONSTRUCTIONS; AND VACCINE FOR TREATMENT OF DISEASES OF LEISHMANIOSIS INFECTIONS

机译:使用DNA表达构建体的方法;使用两个或三个DNA表达构建体;使用DNA表达构建物生产疫苗来治疗利什曼病的疾病;使用两种或三种构建体进行DNA表达以生产疫苗来治疗利什曼病感染的疾病; DNA表达构建;和疫苗治疗利什曼病感染的疾病

摘要

"means for treating leishmaniasis infections". The invention relates to the use of a combination of DNA expression constructs for the manufacture of a medicament for immunization against leishmaniasis infections, as well as a corresponding vaccine. DNA expression constructs themselves are also an object of the invention. according to the invention, it is preferably intended that the p36 lack immunogenic antigen be used in combination with the leishmania infantum thiol-specific antioxidant protein antigen (tsa), the leishmania infantum kinetoplast membrane protein antigen ( kmp-11) and leishmania infantum glycoprotein antigen 63 (gp63), for the generation of an immune response. As plasmids for DNA expression constructs, expression construct plasmids may be used, and preferably the immunologically defined minimalist gene expression constructs (midge) according to the invention are used. Other DNA expression constructs according to the invention are used to produce a leishmaniasis disease vaccine and are part of a corresponding vaccine.
机译:“治疗利什曼病的方法”。本发明涉及DNA表达构建体的组合在制备用于免疫针对利什曼病感染的药物以及相应疫苗中的用途。 DNA表达构建体本身也是本发明的目的。根据本发明,优选将缺乏免疫原性的p36抗原与婴儿利什曼原虫硫醇特异性抗氧化剂蛋白抗原(tsa),婴儿利什曼原虫动质体膜蛋白抗原(kmp-11)和婴儿利什曼原虫糖蛋白抗原组合使用。 63(gp63),用于产生免疫反应。作为用于DNA表达构建体的质粒,可以使用表达构建体质粒,并且优选地使用根据本发明的免疫学定义的极简基因表达构建体(midge)。根据本发明的其他DNA表达构建体用于生产利什曼病疾病疫苗,并且是相应疫苗的一部分。

著录项

  • 公开/公告号BRPI0412913B1

    专利类型

  • 公开/公告日2018-04-03

    原文格式PDF

  • 申请/专利权人 MOLOGEN AG;

    申请/专利号BR2004PI12913

  • 申请日2004-10-22

  • 分类号A61K39/008;A61K31/7088;A61K38;C07K14/44;C12N15/85;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号